# Study on the Pharmacokinetic Effect of Itraconazole on SHR0302 Tablets in Healthy Subjects

> **NCT05404724** · PHASE1 · COMPLETED · sponsor: **Jiangsu HengRui Medicine Co., Ltd.** · enrollment: 14 (actual)

## Conditions studied

- Rheumatoid Arthritis

## Interventions

- **DRUG:** itraconazole、 SHR0302 tablets

## Key facts

- **NCT ID:** NCT05404724
- **Lead sponsor:** Jiangsu HengRui Medicine Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-06-25
- **Primary completion:** 2022-07-11
- **Final completion:** 2022-07-11
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2022-12-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05404724

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05404724, "Study on the Pharmacokinetic Effect of Itraconazole on SHR0302 Tablets in Healthy Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05404724. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*